IPTp Plus ITNs for Malaria Control in Pregnant Women

NCT00209781 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1028

Last updated 2008-03-06

No results posted yet for this study

Summary

We aim to evaluate whether IPT in pregnancy provides any additional benefit to the protection afforded by ITNs.

Conditions

  • Pregnancy

Interventions

DRUG

Sulfadoxine-Pyrimethamine (Fansidar)

DEVICE

ITNs

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Clara Menendez, MD, PhD · Centre for International Health, Hospital Clinic de Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-08-31
Completion
2006-12-31

Countries

  • Mozambique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00209781 on ClinicalTrials.gov